Search research articles
Contact Us
Filters
Showing results (141-150 of 331) with videos related to
Page
of 34
Sort By:
International Journal of Geriatric Psychiatry
|
September 26, 2018
Does the Geriatric Depression Scale measure depression in Parkinson's disease?
Francesca V Lopez, Molly Split, J Vincent Filoteo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 1, 2021
A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
Rodolfo Mundaca-Uribe, Emil Karshalev, Berta Esteban-Fernández de Ávila, et al.
Nature Reviews. Neurology
|
June 10, 2022
Closing the loop for patients with Parkinson disease: where are we?
Hazhir Teymourian, Farshad Tehrani, Katherine Longardner, et al.
International Journal of Geriatric Psychiatry
|
August 23, 2022
Prospective predictors of care partner burden and depression in Parkinson's disease
Nicole Whiteley, Celina F Pluim, Molly Split, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI
Irene Litvan, Dag Aarsland, Charles H Adler, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling
Suborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.
Nature Communications
|
May 20, 2025
Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice
Suborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.
Parkinsonism & Related Disorders
|
April 9, 2014
The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment
Eva Pirogovsky, Dawn M Schiehser, Irene Litvan, et al.
Angewandte Chemie (International Ed. in English)
|
June 19, 2021
Non-Invasive Sweat-Based Tracking of L-Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration
Jong-Min Moon, Hazhir Teymourian, Ernesto De la Paz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2019
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
Nobutaka Sakae, Keith A Josephs, Irene Litvan, et al.
Page
of 34
Search research articles
Search
Showing results (141-150 of 331) with videos related to
Sort By:
Page
of 34
International Journal of Geriatric Psychiatry
|
September 26, 2018
Does the Geriatric Depression Scale measure depression in Parkinson's disease?
Francesca V Lopez, Molly Split, J Vincent Filoteo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 1, 2021
A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
Rodolfo Mundaca-Uribe, Emil Karshalev, Berta Esteban-Fernández de Ávila, et al.
Nature Reviews. Neurology
|
June 10, 2022
Closing the loop for patients with Parkinson disease: where are we?
Hazhir Teymourian, Farshad Tehrani, Katherine Longardner, et al.
International Journal of Geriatric Psychiatry
|
August 23, 2022
Prospective predictors of care partner burden and depression in Parkinson's disease
Nicole Whiteley, Celina F Pluim, Molly Split, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI
Irene Litvan, Dag Aarsland, Charles H Adler, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling
Suborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.
Nature Communications
|
May 20, 2025
Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice
Suborno Jati, Daniel Munoz-Mayorga, Shandy Shahabi, et al.
Parkinsonism & Related Disorders
|
April 9, 2014
The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment
Eva Pirogovsky, Dawn M Schiehser, Irene Litvan, et al.
Angewandte Chemie (International Ed. in English)
|
June 19, 2021
Non-Invasive Sweat-Based Tracking of L-Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration
Jong-Min Moon, Hazhir Teymourian, Ernesto De la Paz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2019
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
Nobutaka Sakae, Keith A Josephs, Irene Litvan, et al.
Page
of 34